Role of thrombophilic gene polymorphisms in branch retinal vein occlusion

Ophthalmology

Volumn 112, Issue 11, 2005, Pages 1910-1915

  Weger, Martin ^a   Renner, Wilfried ^a   Steinbrugger, Iris ^a   Cichocki, Lisa ^a   Temmel, Werner ^a   Stanger, Olaf ^b   El Shabrawi, Yosuf ^a   Lechner, Helga ^a   Schmut, Otto ^a   Haas, Anton ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF SALZBURG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 5 LEIDEN; FIBRINOGEN; GLYCOPROTEIN IIIA; PHOSPHODIESTERASE I; PROTHROMBIN;

ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERCOAGULABILITY; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RETINA VEIN OCCLUSION; RISK; THROMBOPHILIA;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FACTOR V; FACTOR XII; FEMALE; FIBRINOGEN; GENOTYPE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTEGRIN ALPHA2; INTEGRIN BETA3; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREVALENCE; PROTHROMBIN; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOPHILIA;

EID: 27644517288     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2005.05.019     Document Type: Article

References (62)

1. Eye Disease Case-Control Study Group Risk factors for branch retinal vein occlusion Am J Ophthalmol 116 1993 286 296
2. J.B. Blice, G.C. Brown Retinal vascular occlusive disease R.F. Spaide Diseases of the Retina and Vitreous 1999 WB Saunders Philadelphia 109 127
3. B.A. Brown, J.L. Marx, T.P. Ward Homocysteine a risk factor for retinal venous occlusive disease Ophthalmology 109 2002 287 290
4. R. Klein, B.E. Klein, S.E. Moss, S.M. Meuer The epidemiology of retinal vein occlusion the Beaver Dam Eye Study Trans Am Ophthalmol Soc 98 2000 133 141
5. M. Weger, O. Stanger, H. Deutschmann Hyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation as a risk factor in branch retinal vein occlusion Ophthalmology 109 2002 1105 1109
6. M.T. Cahill, S.S. Stinnett, S. Fekrat Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease Am J Ophthalmol 136 2003 1136 1150
7. R. Albisinni, A. Coppola, M. Loffredo Retinal vein occlusion and inherited conditions predisposing to thrombophilia [letter] Thromb Haemost 80 1998 702 703
8. C. Kuhli, L.O. Hattenbach, I. Scharrer High prevalence of resistance to APC in young patients with retinal vein occlusion Graefes Arch Clin Exp Ophthalmol 240 2002 163 168
9. C. Peris Martinez, J. Avino Martinez, M. Diaz-Llopis Branch retinal vein occlusion associated with the 20210 G-to-A prothrombin variant Eur J Ophthalmol 10 2000 177 179
10. K. Greiner, G. Hafner, B. Dick Retinal vascular occlusion and deficiencies in the protein C pathway Am J Ophthalmol 128 1999 69 74
11. L. Hansen, H.L. Kristensen, T. Bek, J. Ingerslev Markers of thrombophilia in retinal vein thrombosis Acta Ophthalmol Scand 78 2000 523 526
12. T. Bombeli, A. Basic, J. Fehr Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems Am J Hematol 70 2002 126 132
13. O. Salomon, J. Moisseiev, N. Rosenberg Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vein occlusion Blood Coagul Fibrinolysis 9 1998 617 622
14. B. Delahousse, S. Arsene, R. Piquemal The 20210A allele of the prothrombin gene is not a risk factor for retinal vein occlusion [letter] Blood Coagul Fibrinolysis 9 1998 447 448
15. D. Kalayci, A. Gurgey, D. Guven Factor V Leiden and prothrombin 20210 A mutations in patients with central and branch retinal vein occlusion Acta Ophthalmol Scand 77 1999 622 624
16. F.Y. Demirci, D.B. Guney, K. Akarcay Prevalence of factor V Leiden in patients with retinal vein occlusion Acta Ophthalmol Scand 77 1999 631 633
17. J.A. Scott, J.J. Arnold, J.M. Currie No excess of factor V:Q506 genotype but high prevalence of anticardiolipin antibodies without antiendothelial cell antibodies in retinal vein occlusion in young patients Ophthalmologica 215 2001 217 221
18. C. Incorvaia, F. Parmeggiani, C. Costagliola The heterozygous 20210 G/A genotype prevalence in patients affected by central and branch retinal vein occlusion a pilot study Graefes Arch Clin Exp Ophthalmol 239 2001 251 256
19. F. Cruciani, A. Moramarco, T. Curto MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risk factors for youth retinal vein occlusion Clin Ter 154 2003 299 303
20. S. Aras, G. Yilmaz, I. Alpas Retinal vein occlusion and factor V Leiden and prothrombin 20210 G:A mutations Eur J Ophthalmol 11 2001 351 355
21. O. Backhouse, L. Parapia, I. Mahomed, D. Lee Familial thrombophilia and retinal vein occlusion Eye 14 2000 13 17
22. A.P. Ciardella, L.A. Yannuzzi, K.B. Freund Factor V Leiden, activated protein C resistance, and retinal vein occlusion Retina 18 1998 308 315
23. K. Greiner, D. Peetz, A. Winkgen Genetic thrombophilia in patients with retinal vascular occlusion Int Ophthalmol 23 1999 155 160
24. R.M. Bertina, B.P. Koeleman, T. Koster Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
25. S.R. Poort, F.R. Rosendaal, P.H. Reitsma, R.M. Bertina A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 1996 3698 3703
26. A.M. Carter, M. Sachchithananthan, S. Stasinopoulos Prothrombin G20210A is a bifunctional gene polymorphism Thromb Haemost 87 2002 846 853
27. F.R. Rosendaal, C.J. Doggen, A. Zivelin Geographic distribution of the 20210 G to A prothrombin variant Thromb Haemost 79 1998 706 708
28. D.C. Rees, M. Cox, J.B. Clegg World distribution of factor V Leiden Lancet 346 1995 1133 1134
29. R.F. Doolittle Fibrinogen and fibrin Annu Rev Biochem 53 1984 195 229
30. S.E. Humphries, S. Ye, P. Talmud European Atherosclerosis Research Study (EARS) Group European Atherosclerosis Research Study genotype at the fibrinogen locus (G-455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment interaction Arterioscler Thromb Vasc Biol 15 1995 96 104
31. T.W. Meade, S. Mellows, M. Brozovic Haemostatic function and ischaemic heart disease principal results of the Northwick Park Heart Study Lancet 2 1986 533 537
32. B. Eber, M. Schumacher Fibrinogen its role in the hemostatic regulation in atherosclerosis Semin Thromb Hemost 2 1993 104 107
33. G.D. Lowe Blood rheology in arterial disease Clin Sci (Lond) 71 1986 137 146
34. E.A. Braat, G. Dooijewaard, D.C. Rijken Fibrinolytic properties of activated FXII Eur J Biochem 263 1999 904 911
35. W.M. Halbmayer, C. Mannhalter, C. Feichtinger Factor XII (Hageman factor) deficiency a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thrombembolism and myocardial infarction [in German] Wien Med Wochenschr 143 2 1993 43 50
36. M. Winter, M. Gallimore, D.W. Jones Should factor XII assays be included in thrombophilia screening? [letter]. Lancet 346 1995 52
37. C. Kuhli, I. Scharrer, F. Koch Factor XII deficiency a thrombophilic risk factor for retinal vein occlusion Am J Ophthalmol 137 2004 459 464
38. A.M. Abu El-Asrar, A.G. Abdel Gader, S. Al-Amro, A.K. Al-Momen Hypercoagulable states in patients with retinal venous occlusion Doc Ophthalmol 95 1998 133 143
39. A.M. Abu El-Asrar, A.K. Al-Momen, S. Al-Amro Prothrombotic states associated with retinal venous occlusion in young adults Int Ophthalmol 20 1996 197 204 97
40. L. Speicher, W. Philipp, F.J. Kunz Factor XII deficiency and central retinal vein occlusion [letter] Lancet 340 1992 237
41. T. Kanaji, T. Okamura, K. Osaki A common genetic polymorphism (46 C to T substitution) in the 5′-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level Blood 91 1998 2010 2014
42. I. Tirado, J.M. Soria, J. Mateo Association after linkage analysis indicates that homozygosity for the 46C→T polymorphism in the F12 gene is a genetic risk factor for venous thrombosis Thromb Haemost 91 2004 899 904
43. P.M. Dodson, J. Westwick, G. Marks beta-Thromboglobulin and platelet factor 4 levels in retinal vein occlusion Br J Ophthalmol 67 1983 143 146
44. P.N. Walsh, R.E. Goldberg, R.L. Tax, L.E. Magargal Platelet coagulant activities and retinal vein thrombosis Thromb Haemost 38 1977 399 406
45. P.M. Dodson, J. Haynes, J. Starczynski The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A a novel risk factor for retinal vein occlusion Eye 17 2003 772 777
46. T.J. Kunicki, R. Orchekowski, D. Annis, Y. Honda Variability of integrin alpha2 beta1 activity on human platelets Blood 82 1993 2693 2703
47. T. Kunicki, M. Kritzik, D.S. Annis, D.J. Nugent Hereditary variation in platelet integrin alpha2 beta1 density is associated with two silent polymorphisms in the alpha2 gene coding sequence Blood 89 1997 1939 1943
48. M. Kritzik, B. Savage, D.J. Nugent Nucleotide polymorphisms in the alpha2 gene define multiple alleles that are associated with differences in platelet alpha2 beta1 density Blood 92 1998 2382 2388
49. B. Savage, F. Almus-Jacobs, Z.M. Ruggeri Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow Cell 94 1998 657 666
50. S. Kulkarni, S.M. Dopheide, C.L. Yap A revised model of platelet aggregation J Clin Invest 105 2000 783 791
51. D. Feng, K. Lindpaintner, M.G. Larson Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism the Framingham Offspring Study Arterioscler Thromb Vasc Biol 19 1999 1142 1147
52. J. Larsson, A. Hillarp The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism PlA2 in patients with central retinal vein occlusion Thromb Res 96 1999 323 327
53. W. Renner, H. Köppel, M. Brodmann Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease Thromb Haemost 83 2000 20 22
54. W. Renner, L. Cichocki, A. Forjanics G-455A polymorphism of the fibrinogen beta gene and deep vein thrombosis Eur J Clin Invest 32 2002 755 758
55. W. Renner, M. Brodmann, M. Winkler The PLA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with peripheral arterial disease [letter] Thromb Haemost 85 2001 745 746
56. S.A. Croft, K.K. Hampton, J.A. Sorrell The GPIa C807T dimorphism associated with platelet collagen receptor density is not a risk factor for myocardial infarction Br J Haematol 106 1999 771 776
57. G. Endler, M. Exner, C. Mannhalter A common C→T polymorphism at nt 46 in the promoter region of coagulation factor XII is associated with decreased factor XII activity Thromb Res 101 2001 255 260
58. T.Y. Wong, E.K.M. Larsen, R. Klein Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli the Atherosclerosis Risk in Communities and Cardiovascular Health Studies Ophthalmology 112 2005 540 547
59. C.C. Kelleher, K.A. Mitropoulos, J. Imeson Hageman factor and risk of myocardial infarction in middle-aged men Atherosclerosis 97 1992 67 73
60. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115 126
61. G.T. Frangieh, W.R. Green, E. Barraquer-Somers, D. Finkelstein Histopathologic study of nine branch retinal vein occlusions Arch Ophthalmol 100 1982 1132 1140
62. J. Zhao, S.M. Sastry, R.D. Sperduto Eye Disease Case-Control Study Group Arteriovenous crossing patterns in branch retinal vein occlusion Ophthalmology 100 1993 423 428